Group leader (Inserm) | axel.innis {at} inserm.fr
Axel did his PhD in structural biology at the University of Cambridge, under the supervision of Prof. Tom Blundell (1998-2002). He then joined the group of Dr. R. Sowdhamini at the National Centre for Biological Sciences in Bangalore as a visiting fellow (2002-2004), where he developed a computational method for identifying functionally important sites in proteins. Following his time in India, Axel joined the laboratory of Prof. Thomas Steitz at Yale University (2004-2012). There, he chose to tackle what was, at the time, a little-known form of translational control: the regulation of ribosomal protein synthesis by the nascent polypeptide. He joined IECB as a group leader in January 2013, was awarded the 2017 Coups d’Elan Prize for French Research from the Bettencourt-Schueller Foundation and was selected as a 2017 EMBO Young Investigator.
Mélanie is optimizing and streamlining in-house methods for the high-throughput study of ribosome-targeting peptides.
melanie.gillard {at} u-bordeaux.fr
Mecit is exploring the functional capabilities of small molecule-sensing arrest peptides
abdulmecit.gokce {at} inserm.fr
Aitor is using the ribosome as a high-throughput selection platform to obtain new antimicrobial peptides
a.manteca {at} iecb.u-bordeaux.fr
Thomas studies the mechanisms of antimicrobial peptide uptake in bacteria
t.perry {at} iecb.u-bordeaux.fr
Anne-Xander is developing new experimental approaches to identify ribosome-arresting peptides in bacteria
ax.van-der-stel {at} iecb.u-bordeaux.fr
Pauline is working on the identification and characterization of peptide-based antibiotic scaffolds
pauline.cossard {at} u-bordeaux.fr
Alba is working on the identification of bacterial arrest peptides with novel functionalities
alba.herrero-del-valle {at} etu.u-bordeaux.fr
Elodie studies the mechanisms by which antibiotics affect bacterial translation.
e.leroy {at} iecb.u-bordeaux.fr